About the Authors
- Satoshi Osaga
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
* E-mail: osaga_satoshi@lilly.com
Affiliation Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Hyogo Prefecture, Japan
- Takeshi Kimura
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Real World Data Co., Ltd., Nakagyo Ward, Kyoto, Kyoto Prefecture, Japan
- Yasuyuki Okumura
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
Affiliation Real World Data Co., Ltd., Nakagyo Ward, Kyoto, Kyoto Prefecture, Japan
- Rina Chin
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
Affiliation Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Hyogo Prefecture, Japan
- Makoto Imori
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
Affiliation Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Hyogo Prefecture, Japan
- Machiko Minatoya
-
Roles Formal analysis, Writing – review & editing
Affiliation Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Hyogo Prefecture, Japan
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: Satoshi Osaga, Rina Chin, Makoto Imori, and Machiko Minatoya are employees of Eli Lilly Japan K.K. and minor shareholders in Eli Lilly and Company. Takeshi Kimura and Yasuyuki Okumura are employees of Real World Data Co, Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials.